Hydroxyzine does not directly damage healthy kidneys in the way that certain painkillers or contrast dyes can. The concern is subtler: hydroxyzine’s main active byproduct is cleared through the kidneys, so when kidney function is already reduced, the drug and its effects can build up in the body. That accumulation raises the risk of side effects and may contribute to further kidney decline through indirect pathways. The relationship between hydroxyzine and kidney health depends heavily on whether your kidneys are working well to begin with.
How Hydroxyzine Leaves Your Body
Hydroxyzine is an older antihistamine prescribed for anxiety, itching, and sometimes as a sedative before procedures. After you take it, your liver converts most of the drug into cetirizine, which many people recognize as the over-the-counter allergy medication Zyrtec. Cetirizine is the primary active metabolite, meaning it is pharmacologically active in the body and responsible for a significant portion of the antihistamine effect you feel.
Cetirizine is predominantly eliminated by the kidneys, with an average elimination half-life of about eight hours in people with normal kidney function.1PubMed. Review of cetirizine hydrochloride for the treatment of allergic disorders This is a fairly standard clearance rate. But in people with kidney impairment, both total body clearance and renal clearance of cetirizine drop significantly.2PubMed. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency When the kidneys cannot flush cetirizine out at the expected pace, it lingers in the bloodstream longer, and each new dose adds more before the previous one has cleared. The result is higher circulating drug levels than intended, which translates into stronger sedation, more pronounced dry mouth, and a greater chance of other side effects.
Why Kidney Disease Changes the Risk Profile
For someone with healthy kidneys, a standard dose of hydroxyzine is processed and eliminated without much fuss. The drug does not appear to cause acute kidney injury on its own in otherwise healthy people. The story changes when the kidneys are already struggling. As kidney filtration declines, the half-life of cetirizine stretches out. Where a healthy kidney might clear most of the metabolite in under a day, an impaired kidney takes considerably longer, and the drug effectively becomes more potent at the same dose.
Hydroxyzine is also not removed by dialysis, which matters for people with severe kidney disease.3Clinical Kidney Journal. Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor If a dialysis patient takes hydroxyzine, the hemodialysis session will not help clear it from the blood. Guidelines suggest that when kidney filtration drops below a very low threshold, doses should be adjusted downward, and clinicians should consider switching to cetirizine itself at a lower dose, since at least with cetirizine the dosing can be more precisely calibrated for kidney function. The fact that hydroxyzine cannot be dialed back once it is in your system makes it a riskier choice for people on dialysis compared to drugs that can be partially cleared during treatment sessions.
Anticholinergic Effects and Kidney Disease Progression
Hydroxyzine belongs to a class of medications with anticholinergic properties, meaning it blocks a neurotransmitter called acetylcholine. This is what causes the familiar side effects: dry mouth, constipation, urinary retention, drowsiness, and mental fogginess. Many commonly prescribed drugs have anticholinergic effects, and when a patient takes several of them at once, the combined “anticholinergic burden” adds up.
A recent study looking specifically at anticholinergic burden and chronic kidney disease found that a high cumulative anticholinergic load was independently associated with CKD progression, with roughly a 50 percent higher hazard of worsening kidney function compared to patients with no anticholinergic burden.4Journal of Epidemiology and Population Health. Anticholinergic burden and chronic kidney disease progression Among patients with a high anticholinergic score, the most common combination was furosemide (a diuretic widely prescribed for fluid overload in kidney patients) taken alongside hydroxyzine or another anticholinergic drug. This does not mean hydroxyzine alone was responsible for the kidney decline. It means that in the context of multiple medications with anticholinergic properties, the combined effect tracked with faster progression of kidney disease.
The mechanism is not fully pinned down, but anticholinergic drugs can reduce bladder function and promote urinary retention, which in turn may raise pressure on the kidneys over time. They also lower blood pressure in some patients or cause dehydration through reduced fluid intake (dry mouth discourages drinking), both of which can stress already compromised kidneys. The takeaway is less about hydroxyzine as a single villain and more about the total medication picture: if you are already taking other anticholinergic drugs and you have kidney disease, adding hydroxyzine piles on additional risk.
Heart Rhythm Concerns Specific to Kidney Patients
One of the less intuitive risks of hydroxyzine in people with kidney disease involves the heart. Hydroxyzine is known to prolong the QT interval, a measurement on an electrocardiogram that reflects how long the heart takes to reset between beats. When the QT interval stretches too far, it increases the risk of a dangerous irregular heartbeat.
In a study of patients with chronic kidney disease, hydroxyzine was one of eight medications associated with statistically significant QT prolongation, adding about four milliseconds to the corrected QT interval after adjusting for other factors.5Clinical Journal of the American Society of Nephrology. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations Four milliseconds may sound trivial, and in a healthy person it probably is. But CKD patients are already at elevated baseline risk for QT prolongation because of electrolyte disturbances, particularly fluctuations in potassium and calcium, which are common as kidney filtration deteriorates. The same study found that QT interval was inversely related to serum potassium and calcium levels. So a CKD patient who happens to have low potassium from a diuretic, takes hydroxyzine, and is also on another QT-prolonging medication is stacking several risk factors at once.
Medications classified as QT-prolonging were taken at about three quarters of visits in this CKD cohort, and more than one such drug was used at a third of visits.5Clinical Journal of the American Society of Nephrology. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations That is a remarkably common scenario, and it underscores why nephrologists and pharmacists tend to scrutinize hydroxyzine prescriptions in this population more carefully than they would for a patient with normal kidney function.
Can Hydroxyzine Cause Acute Kidney Injury?
There is limited direct evidence that hydroxyzine causes acute kidney injury (AKI) on its own. One large electronic health records mining study examined drug pairs that might trigger AKI and flagged a possible signal when hydroxyzine was combined with bromazepam, a benzodiazepine. The initial statistical screen showed an elevated odds ratio, but when researchers actually reviewed the medical charts of those patients, the signal was not confirmed as a causal link.6PubMed. Detection of Drug-Drug Interactions Inducing Acute Kidney Injury by Electronic Health Records Mining In other words, AKI was present and the drugs were present, but other factors likely explained the kidney damage. This is a common challenge in pharmacovigilance: sick patients take many medications, and correlation between a drug and an outcome does not prove the drug caused the outcome.
No well-established pattern of hydroxyzine causing direct tubular damage or interstitial nephritis (an inflammatory kidney reaction triggered by some drugs) has emerged in the literature in the way it has for, say, certain antibiotics or nonsteroidal anti-inflammatory drugs. If hydroxyzine harms kidneys, the evidence so far points to indirect routes: anticholinergic burden over time, drug accumulation in patients who already have kidney disease, and the cardiac risks that compound in CKD rather than a direct toxic hit to kidney tissue.
Hydroxyzine Is Still Prescribed to Kidney Patients for Itching
Here is where the picture gets more nuanced. Severe itching, known as uremic pruritus, is one of the most common and miserable symptoms for people on hemodialysis. It affects a majority of dialysis patients at some point and substantially degrades quality of life. Despite the concerns outlined above, hydroxyzine has historically been one of the go-to treatments for this itching.
A network meta-analysis of randomized trials comparing systemic drugs for uremic pruritus in hemodialysis patients found that gabapentin had the highest probability of being the most effective option for relief, followed by cromolyn sodium and then hydroxyzine.7Frontiers in Medicine. Efficacy and safety of different systemic drugs in the treatment of uremic pruritus among hemodialysis patients: a network meta-analysis based on randomized clinical trials Hydroxyzine ranked respectably, but not at the top. Gabapentin and thalidomide were associated with higher rates of drug response overall, though gabapentin also came with a higher likelihood of adverse events like dizziness.
This puts nephrologists in a real bind. They have a patient suffering from intractable itching, and hydroxyzine does provide relief, but it also cannot be cleared by dialysis and carries sedation, anticholinergic, and cardiac risks in this exact population. The trend in recent years has been to move toward gabapentin or newer agents like difelikefalin as first-line choices for uremic pruritus, reserving hydroxyzine for cases where other options fail or are not tolerated. If you are on dialysis and currently take hydroxyzine for itching, this is worth a conversation with your nephrologist about whether a better-suited alternative exists for your situation.
Older Adults Face Compounded Risks
Kidney function declines naturally with age, even in people who have never been diagnosed with kidney disease. Many older adults have mildly reduced kidney filtration without knowing it, because standard blood creatinine measurements can look normal even when actual filtration has dropped. This matters because hydroxyzine is frequently prescribed to older adults for anxiety, insomnia, and itching, and the combination of age-related kidney decline with the drug’s anticholinergic profile creates a compounding problem.
Anticholinergic medications as a class are already flagged by geriatric prescribing guidelines (such as the Beers Criteria) as potentially inappropriate for older adults because of the risk of confusion, falls, and cognitive impairment. The cognitive effects of anticholinergic drugs are amplified when the drug is not being cleared efficiently, which is exactly what happens when kidney function is reduced. Hydroxyzine is specifically listed in prescribing guidance for kidney disease patients as a drug that may need dose reduction or substitution with cetirizine at lower doses when filtration rates are low.3Clinical Kidney Journal. Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor
The practical upshot for an older person taking hydroxyzine: even if no one has told you that you have kidney disease, it is worth asking whether your kidney function has been checked recently. A simple blood test for estimated glomerular filtration rate can reveal whether your kidneys are clearing drugs as expected. If filtration is reduced, your prescriber may want to lower the hydroxyzine dose or switch to an alternative that does not rely as heavily on kidney clearance.
What to Do If You Take Hydroxyzine and Have Kidney Concerns
If your kidneys are healthy by all available measures, hydroxyzine at standard prescribed doses is unlikely to cause kidney damage. The drug has been used for decades, and there is no established pattern of nephrotoxicity in people with normal renal function. The risks are concentrated in specific populations: people who already have chronic kidney disease, people on dialysis, older adults with unrecognized kidney decline, and anyone taking multiple anticholinergic medications simultaneously.
A few practical steps can reduce your risk:
- Know your kidney numbers: Ask your doctor for your eGFR if you have not had it checked recently, especially if you are over 60 or have diabetes, high blood pressure, or a family history of kidney disease.
- Review your full medication list: The anticholinergic burden finding means the problem is cumulative. Hydroxyzine alone may be fine, but hydroxyzine plus an overactive bladder drug plus a tricyclic antidepressant creates a combined load that tracks with kidney disease progression.
- Watch for accumulation symptoms: Excessive drowsiness, confusion, very dry mouth, difficulty urinating, or a racing heart after taking hydroxyzine may signal that the drug is not being cleared quickly enough. These warrant a call to your prescriber.
- Ask about alternatives: For anxiety, options like buspirone or certain SSRIs do not carry anticholinergic burden. For itching in kidney disease, gabapentin has emerged as a preferred choice. For mild allergies, second-generation antihistamines like loratadine are less sedating and have a more predictable clearance profile.
How Hydroxyzine Compares to Other Antihistamines for Kidney Safety
First-generation antihistamines like hydroxyzine and diphenhydramine share the anticholinergic profile that creates problems in kidney patients. Second-generation antihistamines like cetirizine, loratadine, and fexofenadine were designed specifically to minimize these anticholinergic and sedative effects. Ironically, since cetirizine is the very metabolite your body makes from hydroxyzine, prescribing cetirizine directly gives clinicians more precise control over the dose a kidney patient actually receives, rather than relying on the liver to convert hydroxyzine at a variable rate.
Cetirizine still requires dose adjustments in kidney impairment because it is renally cleared, but its pharmacokinetics are better characterized and the dosing is more predictable.2PubMed. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency Fexofenadine has the advantage of being partly eliminated through the stool rather than entirely through the kidneys, which makes it another option that some nephrologists prefer for allergic symptoms in patients with reduced kidney function. Loratadine is metabolized by the liver and has minimal renal excretion, though it has its own drug interaction profile to consider.
None of these second-generation alternatives carry the same anxiolytic effect that makes hydroxyzine useful for anxiety and procedural sedation. That dual role as antihistamine and mild anxiolytic is what keeps hydroxyzine in rotation despite its less favorable profile in kidney disease. For patients who rely on hydroxyzine specifically for its calming effects rather than its antihistamine properties, the conversation shifts to anxiety-specific alternatives that bypass the kidney clearance issue entirely.